Navigation Links
QIAGEN Acquires Exclusive Licence for Key PI3K gene
Date:2/8/2010

nalized healthcare and companion diagnostics), our relationships with customers, suppliers and strategic partners, competition, changes in technology, fluctuations in demand, regulatory requirements, identifying, developing and producing integrated products differentiated from our competitors' products, market acceptance of our products, and integration of acquired technologies and businesses. For further information, refer to our filings with the SEC, including our latest Form 20-F. Information in this release is as of the date of the release, and we undertake no duty to update this information unless required by law.

    Contacts:

    Dr. Solveigh Mahler
    Director Investor Relations
    QIAGEN N.V.
    +49-2103-29-11710
    e-mail: solveigh.maehler@qiagen.com

    Albert F. Fleury
    Director Corporate Finance and
    Investor Relations North America
    QIAGEN N.V.
    +1-301-944-7028
    e-mail: albert.fleury@qiagen.com

    Dr. Thomas Theuringer
    Associate Director Public Relations
    QIAGEN GmbH
    +49-2103-29-11826
    email: thomas.theuringer@qiagen.com

    Joanne Cross
    Marketing Manager
    DxS - a QIAGEN Company
    Phone: +44(0)7540-121-673
    Email: joanne.cross@qiagen.com

SOURCE Qiagen


'/>"/>
SOURCE Qiagen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
2. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
3. Plexus Awarded Development Contract With QIAGEN
4. QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
5. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10
6. QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations
7. SciQuest Announces Strategic Alliance with QIAGEN
8. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2008 Financial Results Call Set for August 5
9. Webcast Alert: QIAGEN N.V. Announces First Quarter 2008 Earnings Conference Call
10. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Fourth Quarter and Year End 2007 Earnings and 2008 Guidance Conference Call on the Web
11. Cell Biosciences Acquires Protein Forest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... PA (PRWEB) January 15, 2014 The Pittcon ... publisher of Food Safety Tech , an e-Journal and ... signed an agreement for the second year for the co-location ... Pittcon 2014. The partnership provides that the registration fee to ...
(Date:1/15/2014)... Look inside the new Preferred Solutions® catalog ... from fluid handling to instruments to supplies. Many items ... order. , Preferred Solutions features a full selection ... model for precise flow control and dispensing to I/P® ...
(Date:1/15/2014)... JOSE, California , January 15, 2014 ... cancer, today announced the appointment of Thomas C Reynolds MD, ... 20 years, development experience gained in the biotechnology industry, most ... "I am delighted to welcome Tom at this transformative time ...
(Date:1/15/2014)... This webinar will focus on EMA and FDA ... biosimilars. , Regulatory frameworks are evolving many countries to ... complex nature of biopharmaceuticals makes the demonstration of biosimilarity ... Based on the specific aspects of biosimilar drug development ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2
... BSP Biological Signal Processing Ltd. (BSP) (TASE: ... accurate diagnosis of Coronary Artery Disease (CAD), recently announced ... evaluating the performance of the company,s HyperQ technology in ... results was accepted for publication in the prestigious ...
... 2011 Cell Therapeutics, Inc. (the "Company") (NASDAQ and ... Meeting of Shareholders (the "Annual Meeting") held on Friday, November ... elected James A. Bianco, M.D., Vartan Gregorian, Ph.D., and ... s Board of Directors until the Company, s 2014 ...
... 2011 Callibra, Inc. dba Discharge 1-2-3 of ... ten winners of the 2011 Chicago Innovation Awards for their ... an event held at Chicago,s Harris Theater on Tuesday, November ... Awards, celebrating its 10th year, is the Chicago region,s foremost ...
Cached Biology Technology:Positive Clinical Study Results for BSP's HyperQ Technology 2Positive Clinical Study Results for BSP's HyperQ Technology 3Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders 2Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award 2Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award 3
(Date:4/24/2014)... the Scientific Reports journal. , CSIC researcher Carles ... of CSIC and Pompeu Fabra University-UPF), explains: "When the Y ... that it did not match with the DNA recovered from ... genome and to make a functional interpretation in order to ... , The functional genome analysis was based on two ...
(Date:4/24/2014)... could now be treated in three days, rather than two ... Cryptococcus a form of yeast - infections ... They are found in many parts of the world, ... people with weakened immune systems. This infection kills up to ... tested the effects of the most commonly used drug on ...
(Date:4/24/2014)... With a new generation of military veterans returning home ... become a prominent concern in American medical institutions and ... 35 percent of personnel deployed to Iraq and Afghanistan ... South Carolina School of Medicine is shedding light on ... and surprising ways. , The rise in PTSD has ...
Breaking Biology News(10 mins):The blood preserved in the pumpkin did not belong to Louis XVI 2Treatment for deadly yeast disease reduced to 3 days 2New study links inflammation in those with PTSD to changes in microRNA 2New study links inflammation in those with PTSD to changes in microRNA 3
... peat moss Sphagnum palustre appears to be a ... researchers have discovered. The study is published in New ... plant of the Hawaiian population appears to have been produced ... back to a single parent. Surprisingly, the genetic diversity ...
... California, Riverside scientists released a natural enemy of the ... control the spread of the psyllid, an invasive pest that ... trees in home landscapes. This is the first time the ... Riverside Executive Vice Chancellor Dallas Rabenstein and ...
... 15th anniversary of the return of wolves to Yellowstone National ... health is emerging, scientists conclude in a new report. ... young aspen and willow trees has diminished as elk populations ... increased. Trees and shrubs have begun recovering along some streams, ...
Cached Biology News:UC Riverside scientists release natural enemy of Asian citrus psyllid 2UC Riverside scientists release natural enemy of Asian citrus psyllid 3UC Riverside scientists release natural enemy of Asian citrus psyllid 4An ecosystem being transformed - Yellowstone 15 years after the return of wolves 2An ecosystem being transformed - Yellowstone 15 years after the return of wolves 3
...
...
Cell Lysis Buffer is used to lyse cells under nondenaturing conditions....
Rad 50 Immunogen: c-terminal mRad 50 (604 amino acids). Storage: 4 C...
Biology Products: